Finance

Lists
4549:TYO
Eiken Chemical Co Ltd
2 351,00 JP¥
+0,64%
(+15,00) 1D
7 қаз., 11:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
2 330 JP¥
High
2 357 JP¥
Low
2 329 JP¥
Mkt. cap
81,21 млрд
Avg. vol.
174,21 м.
Volume
47,00 мың
Dividend
2,47%
Quarterly dividend
14 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
21,81
52-wk high
3 500 JP¥
52-wk low
2 021 JP¥
EPS
108 JP¥
Shares outstanding
36,88 млн
No. of employees
696
Open
2 330 JP¥
High
2 357 JP¥
Low
2 329 JP¥
Mkt. cap
81,21 млрд
Avg. vol.
174,21 м.
Volume
47,00 мың
Dividend
2,47%
Quarterly dividend
14 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
21,81
52-wk high
3 500 JP¥
52-wk low
2 021 JP¥
EPS
108 JP¥
Shares outstanding
36,88 млн
No. of employees
696
News stories
From web sources and news partners
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees696
Founded1939 ж. 20 ақп.
Headquarters-
SectorMedical device
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
10,23 млрд
10,95 млрд
10,52 млрд
10,73 млрд
Cost of goods sold
5,96 млрд
6,70 млрд
6,97 млрд
6,65 млрд
Cost of revenue
5,96 млрд
6,70 млрд
6,97 млрд
6,65 млрд
Research and development expenses
-
-
3,68 млрд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,34 млрд
3,20 млрд
-262,00 млн
3,41 млрд
Operating expense
3,34 млрд
3,20 млрд
3,41 млрд
3,41 млрд
Total operating expenses
9,30 млрд
9,90 млрд
10,38 млрд
10,06 млрд
Operating income
928,00 млн
1,05 млрд
141,00 млн
668,00 млн
Other non operating income
6,00 млн
-54,00 млн
19,00 млн
-4,00 млн
EBT including unusual items
2,91 млрд
1,00 млрд
102,00 млн
640,00 млн
EBT excluding unusual items
915,00 млн
995,00 млн
-1,89 млрд
640,00 млн
Income tax expense
535,00 млн
260,00 млн
116,00 млн
195,00 млн
Effective tax rate
18,36%
25,92%
113,73%
30,47%
Other operating expenses
-
-
-
-
Net income
2,38 млрд
743,00 млн
-14,00 млн
445,00 млн
Net profit margin
23,25%
6,79%
-0,13%
4,15%
Earnings per share
-
-
-
-
Interest and investment income
8,00 млн
4,00 млн
5,00 млн
7,00 млн
Interest expense
-5,00 млн
-5,00 млн
-15,00 млн
-19,00 млн
Net interest expenses
3,00 млн
-1,00 млн
-10,00 млн
-12,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,50 млрд
1,62 млрд
775,00 млн
1,30 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары